Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness

Sponsor
University of Washington (Other)
Overall Status
Completed
CT.gov ID
NCT03062267
Collaborator
(none)
49
2
2
32
24.5
0.8

Study Details

Study Description

Brief Summary

Testing an mHealth mobile interventionist texting program on illness management.

Condition or Disease Intervention/Treatment Phase
  • Other: Mobile Interventionist
N/A

Detailed Description

The ultimate objective is to evaluate a validated mHealth intervention that can be realistically integrated into community mental health settings to increase the availability, reach, and broad impact of illness management approaches for people with serious mental illness (SMI).

Study Design

Study Type:
Interventional
Actual Enrollment :
49 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness
Actual Study Start Date :
Oct 1, 2017
Actual Primary Completion Date :
May 31, 2020
Actual Study Completion Date :
May 31, 2020

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Treatment as Usual

Treatment as usual for 3 months.

Experimental: Mobile Interventionist

Participants will exchange text messages with a mobile interventionist throughout the day for 3 months.

Other: Mobile Interventionist
A mobile interventionist is a trained clinician who provides supportive messaging through text messages via mobile devices (i.e. basic / smartphones)

Outcome Measures

Primary Outcome Measures

  1. Psychiatric Symptoms [Change from baseline to 3 months and 6 months]

    Assessed with the Psychotic Symptom Rating Scales (PSYRATS). The PSYRATS inquires about the specific dimensions of hallucinations and delusions. There are 17 items and each item is rated from 0 (absent) to 4 (severe). The PSYRATS has 2 subscales: the auditory hallucinations subscale (AHS) consisting of 11 items, and the delusions subscale (DS) consisting of 6 items. These subscale scores are added to create a total score ranging from 0-68. Higher scores indicate worse symptoms.

  2. Psychiatric Symptoms [Change from baseline to 3 months and 6 months]

    Assessed with the Beck Depression Inventory (BDI). The Beck Depression Inventory is a psychometric test for measuring the severity of depression. There are 21 items, each rated from 0-3, and total scores range from 0-63. Higher scores indicate more severe depressive symptoms.

Secondary Outcome Measures

  1. Recovery [Change from baseline to 3 months and 6 months]

    Assessed with the Recovery Assessment Scale (RAS). This scale measures mental health recovery. There are 24 items, each rated from 1 (disagree) to 5 (agree), and total scores range from 24-120. Higher scores indicate better recovery.

Other Outcome Measures

  1. Satisfaction With Treatment [3 months]

    Assessed with satisfaction items established from previous SMI research. This measure consists of 5 items, each rated from 1 (strongly disagree) to 7 (strongly agree), and total scores range from 5-35. Higher scores indicate more satisfaction with treatment.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Chart diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or major depressive disorder;

  2. 18 years or older;

  3. A rating of "3" or higher on one of three Patient Activation items;

  4. Ownership of a mobile phone with call/text plan (research staff will offer assistance in accessing the Federal Lifeline Assistance Program to people who do not have a mobile phone and/or call/text plan if they are otherwise eligible);

  5. Receiving community based treatment services.

Exclusion Criteria:
  1. Hearing, vision, or motor impairment that make it impossible to operate a mobile phone (determined using the individual's device for screening);

  2. English reading level below 4th grade (determined using the reading section from the Wide Range Achievement Test - 4th Edition (WRAT-4).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Thresholds Chicago Illinois United States 60290
2 Frontier Behavioral Health Spokane Washington United States 99207

Sponsors and Collaborators

  • University of Washington

Investigators

  • Principal Investigator: Dror Ben-Zeev, PhD, University of Washington

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Dror Ben-Zeev, Professor, School of Medicine: Psychiatry and Behavioral Sciences, University of Washington
ClinicalTrials.gov Identifier:
NCT03062267
Other Study ID Numbers:
  • STUDY00001274
First Posted:
Feb 23, 2017
Last Update Posted:
Nov 9, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dror Ben-Zeev, Professor, School of Medicine: Psychiatry and Behavioral Sciences, University of Washington
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail No significant events to report that occurred after participant enrollment but prior to assignment of participants to an arm.
Arm/Group Title Treatment as Usual Mobile Interventionist
Arm/Group Description Treatment as usual for 3 months. Participants will exchange text messages with a mobile interventionist throughout the day for 3 months. Mobile Interventionist: A mobile interventionist is a trained clinician who provides supportive messaging through text messages via mobile devices (i.e. basic / smartphones)
Period Title: Overall Study
STARTED 12 37
COMPLETED 10 32
NOT COMPLETED 2 5

Baseline Characteristics

Arm/Group Title Treatment as Usual Mobile Interventionist Total
Arm/Group Description Treatment as usual for 3 months. Participants will exchange text messages with a mobile interventionist throughout the day for 3 months. Mobile Interventionist: A mobile interventionist is a trained clinician who provides supportive messaging through text messages via mobile devices (i.e. basic / smartphones) Total of all reporting groups
Overall Participants 12 37 49
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
43.3
(12.0)
45.4
(11.1)
44.8
(11.2)
Sex/Gender, Customized (Count of Participants)
Female
7
58.3%
15
40.5%
22
44.9%
Male
5
41.7%
22
59.5%
27
55.1%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
3
25%
3
8.1%
6
12.2%
Not Hispanic or Latino
9
75%
33
89.2%
42
85.7%
Unknown or Not Reported
0
0%
1
2.7%
1
2%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
0
0%
0
0%
Asian
0
0%
1
2.7%
1
2%
Native Hawaiian or Other Pacific Islander
0
0%
1
2.7%
1
2%
Black or African American
2
16.7%
10
27%
12
24.5%
White
7
58.3%
17
45.9%
24
49%
More than one race
2
16.7%
6
16.2%
8
16.3%
Unknown or Not Reported
1
8.3%
2
5.4%
3
6.1%
Region of Enrollment (participants) [Number]
United States
12
100%
37
100%
49
100%

Outcome Measures

1. Primary Outcome
Title Psychiatric Symptoms
Description Assessed with the Psychotic Symptom Rating Scales (PSYRATS). The PSYRATS inquires about the specific dimensions of hallucinations and delusions. There are 17 items and each item is rated from 0 (absent) to 4 (severe). The PSYRATS has 2 subscales: the auditory hallucinations subscale (AHS) consisting of 11 items, and the delusions subscale (DS) consisting of 6 items. These subscale scores are added to create a total score ranging from 0-68. Higher scores indicate worse symptoms.
Time Frame Change from baseline to 3 months and 6 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment as Usual Mobile Interventionist
Arm/Group Description Treatment as usual for 3 months. Participants will exchange text messages with a mobile interventionist throughout the day for 3 months. Mobile Interventionist: A mobile interventionist is a trained clinician who provides supportive messaging through text messages via mobile devices (i.e. basic / smartphones)
Measure Participants 12 37
Score at Baseline
5.2
(11.2)
19.6
(20.4)
Score at 3 months
6.2
(14.4)
15.1
(16.7)
Score at 6 months
.6
(1.9)
17.9
(19.1)
2. Primary Outcome
Title Psychiatric Symptoms
Description Assessed with the Beck Depression Inventory (BDI). The Beck Depression Inventory is a psychometric test for measuring the severity of depression. There are 21 items, each rated from 0-3, and total scores range from 0-63. Higher scores indicate more severe depressive symptoms.
Time Frame Change from baseline to 3 months and 6 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment as Usual Mobile Interventionist
Arm/Group Description Treatment as usual for 3 months. Participants will exchange text messages with a mobile interventionist throughout the day for 3 months. Mobile Interventionist: A mobile interventionist is a trained clinician who provides supportive messaging through text messages via mobile devices (i.e. basic / smartphones)
Measure Participants 12 37
Score at Baseline
18.5
(13.7)
18.5
(11.4)
Score at 3 Months
17.2
(11.3)
23.4
(12.4)
Score at 6 Months
15.5
(11.2)
14.8
(10.3)
3. Secondary Outcome
Title Recovery
Description Assessed with the Recovery Assessment Scale (RAS). This scale measures mental health recovery. There are 24 items, each rated from 1 (disagree) to 5 (agree), and total scores range from 24-120. Higher scores indicate better recovery.
Time Frame Change from baseline to 3 months and 6 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment as Usual Mobile Interventionist
Arm/Group Description Treatment as usual for 3 months. Participants will exchange text messages with a mobile interventionist throughout the day for 3 months. Mobile Interventionist: A mobile interventionist is a trained clinician who provides supportive messaging through text messages via mobile devices (i.e. basic / smartphones)
Measure Participants 12 37
Score at Baseline
91.8
(14.6)
89.8
(17.3)
Score at 3 Months
90.0
(13.8)
92.9
(15.5)
Score at 6 Months
93.8
(13.1)
94.4
(14.9)
4. Other Pre-specified Outcome
Title Satisfaction With Treatment
Description Assessed with satisfaction items established from previous SMI research. This measure consists of 5 items, each rated from 1 (strongly disagree) to 7 (strongly agree), and total scores range from 5-35. Higher scores indicate more satisfaction with treatment.
Time Frame 3 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Treatment as Usual Mobile Interventionist
Arm/Group Description Treatment as usual for 3 months. Participants will exchange text messages with a mobile interventionist throughout the day for 3 months. Mobile Interventionist: A mobile interventionist is a trained clinician who provides supportive messaging through text messages via mobile devices (i.e. basic / smartphones)
Measure Participants 12 37
Mean (Standard Deviation) [score on a scale]
28.2
(6.2)
30.1
(6.1)

Adverse Events

Time Frame 6 months.
Adverse Event Reporting Description
Arm/Group Title Treatment as Usual Mobile Interventionist
Arm/Group Description Treatment as usual for 3 months. Participants will exchange text messages with a mobile interventionist throughout the day for 3 months. Mobile Interventionist: A mobile interventionist is a trained clinician who provides supportive messaging through text messages via mobile devices (i.e. basic / smartphones)
All Cause Mortality
Treatment as Usual Mobile Interventionist
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/12 (0%) 0/37 (0%)
Serious Adverse Events
Treatment as Usual Mobile Interventionist
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/12 (0%) 0/37 (0%)
Other (Not Including Serious) Adverse Events
Treatment as Usual Mobile Interventionist
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/12 (0%) 0/37 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Principal Investigator
Organization University of Washington
Phone (206) 685-9655
Email dbenzeev@uw.edu
Responsible Party:
Dror Ben-Zeev, Professor, School of Medicine: Psychiatry and Behavioral Sciences, University of Washington
ClinicalTrials.gov Identifier:
NCT03062267
Other Study ID Numbers:
  • STUDY00001274
First Posted:
Feb 23, 2017
Last Update Posted:
Nov 9, 2020
Last Verified:
Oct 1, 2020